Related Experiment Videos
A novel antioxidant gene from Mycobacterium tuberculosis
1Division of International Medicine and Infectious Disease, Department of Medicine, Cornell University Medical College, New York 10021, USA.
The Journal of Experimental Medicine
|January 7, 1998
Summary
Researchers identified a novel gene, noxR1, in Mycobacterium tuberculosis that enhances resistance to reactive nitrogen intermediates (RNI) and reactive oxygen intermediates (ROI). This discovery may lead to new strategies for controlling tuberculosis.
Area of Science:
- Microbiology
- Immunology
- Molecular Biology
Background:
- Macrophages produce reactive nitrogen intermediates (RNI) and reactive oxygen intermediates (ROI) as antimicrobial agents.
- Mycobacterium tuberculosis is a pathogen that causes tuberculosis.
Purpose of the Study:
- To identify novel genes in Mycobacterium tuberculosis involved in antimicrobial resistance.
- To investigate the role of these genes in resistance to RNI and ROI.
Main Methods:
- Cloning of the noxR1 gene from Mycobacterium tuberculosis.
- Expression of noxR1 in Escherichia coli and Mycobacterium smegmatis.
- Assessing bacterial resistance to RNI and ROI under various conditions.
Main Results:
- The noxR1 gene conferred enhanced resistance to both RNI and ROI in Escherichia coli and Mycobacterium smegmatis.
- This resistance was observed against both exogenous and endogenous sources of RNI and ROI.
- The study identified a novel RNI resistance mechanism in mycobacteria and a new ROI resistance mechanism.
Conclusions:
- The noxR1 gene plays a significant role in protecting bacteria against RNI and ROI.
- Targeting the noxR1 pathway could be a potential therapeutic strategy to enhance macrophage control of tuberculosis.